Cargando…
Comparison of pharmacokinetic and safety profiles between Bemfola(®) and Gonal-f(®) after subcutaneous application
Recombinant human follicle stimulating hormone (r-hFSH) is effective and safe for controlled ovarian stimulation. Bemfola(®) (Finox AG, Burgdorf, Switzerland), a new biosimilar r-hFSH, has proven comparable non-clinical pharmacological profiles to those of the widely used Gonal-f(®) (Serono Pharma S...
Autores principales: | Wolzt, Michael, Gouya, Ghazeleh, Sator, Michael, Hemetsberger, Thomas, Irps, Charlotte, Rettenbacher, Manfred, Vcelar, Brigitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866993/ https://www.ncbi.nlm.nih.gov/pubmed/25633239 http://dx.doi.org/10.1007/s13318-015-0257-6 |
Ejemplares similares
-
In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f)
por: Mastrangeli, Renato, et al.
Publicado: (2017) -
Comparing a biosimilar follitropin alfa (Cinnal-fⓇ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT
por: Hossein Rashidi, Batool, et al.
Publicado: (2021) -
Tetragonal polymorph of 5,5-dichlorobarbituric acid
por: Gelbrich, Thomas, et al.
Publicado: (2011) -
Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap(®) (XM17), Comparability with Gonal-f(®), and Performance/Consistency
por: Winstel, Rainer, et al.
Publicado: (2017) -
Perfect k-Colored Matchings and [Formula: see text] -Gonal Tilings
por: Aichholzer, Oswin, et al.
Publicado: (2018)